Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Amicus Therapeutics (FOLD)

Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Stock Index Futures Tread Water Ahead of Key U.S. PPI Data and Powell Remarks

June S&P 500 E-Mini futures (ESM24) are up +0.02%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.03% this morning as investors geared up for crucial U.S. producer inflation data while also awaiting...

ESM24 : 5,295.50s (+0.81%)
NQM24 : 18,591.00s (-0.08%)
INCY : 57.79 (+0.86%)
INTC : 30.85 (+2.19%)
SQSP : 44.00 (+0.48%)
AMAT : 215.08 (-0.67%)
HD : 334.87 (+1.73%)
ALC.Z.IX : 80.900 (+0.90%)
DHER.D.DX : 27.920 (-1.66%)
RHM.D.DX : 526.700 (+1.76%)
FULC : 7.85 (+2.61%)
FOLD : 9.80 (-0.81%)
Amicus Therapeutics: Q1 Earnings Snapshot

Amicus Therapeutics: Q1 Earnings Snapshot

FOLD : 9.80 (-0.81%)
2 ‘Strong-Buy’-Rated Stocks With Around 50% Upside

Wall Street predicts that these rapidly expanding growth stocks will generate outsized gains this year.

$SPX : 5,277.51 (+0.80%)
$NASX : 16,735.02 (-0.01%)
CVE : 20.82 (+1.12%)
FOLD : 9.80 (-0.81%)
NGG24 : 2.490s (-8.19%)
Amicus Therapeutics: Q3 Earnings Snapshot

Amicus Therapeutics: Q3 Earnings Snapshot

FOLD : 9.80 (-0.81%)
WuXi Biologics Congratulates Amicus Therapeutics on U.S. FDA Approval for New Treatment for Pompe Disease

/PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), congratulates...

FOLD : 9.80 (-0.81%)
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023

Stocks that traded heavily or had substantial price changes on Friday: Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall

OPK : 1.3700 (-2.84%)
MTN : 188.72 (+1.91%)
FOLD : 9.80 (-0.81%)
BLK : 772.03 (+1.33%)
NKE : 95.05 (+1.71%)
WuXi Biologics Reports Solid 2023 Interim Results

Revenue Increased by 17.8% Y-o-Y to RMB8,492.0 Million Adjusted Net Profit Rose by 0.4% to RMB2,925.6 Million Non-COVID Revenue Achieved 59.7% Y-o-Y Growth,...

FOLD : 9.80 (-0.81%)
Amicus Therapeutics: Q2 Earnings Snapshot

Amicus Therapeutics: Q2 Earnings Snapshot

FOLD : 9.80 (-0.81%)
Company News for May 11, 2023

Companies in The news Are: VSH,COHRICL,FOLD

FOLD : 9.80 (-0.81%)
VSH : 23.63 (+0.98%)
COHR : 57.06 (-3.60%)
ICL : 4.73 (+0.42%)
Amicus (FOLD) Q1 Earnings Miss, Galafold Sales Grow

Amicus (FOLD) incurs wider-than-expected loss in the first quarter. Revenues, however, beat estimates. The company reiterates its 2023 guidance.

FOLD : 9.80 (-0.81%)
RCUS : 15.07 (+0.94%)
ALLO : 2.50 (+1.63%)
OCUP : 1.6800 (unch)

Barchart Exclusives

3 High-yield Dividend Stocks Could Soar 30% Or More Within 12 Months
Discover 3 high-yield dividend stocks that are also highly rated. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar